Sanofi opens $925M CAD Fluzone High-Dose facility in Toronto
Sanofi inaugurated the Charles Best Building in Toronto, a $925M CAD facility to produce Fluzone High-Dose. It is fully operational and pending regulatory approval is expected to begin production in early 2027 for the 2027–28 flu season.
Sanofi inaugurated the Charles Best Building in Toronto, a $925M CAD facility to produce Fluzone High-Dose. The site is fully operational and, pending regulatory approval, is expected to begin production in early 2027 for the 2027—28 flu season.